BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 25448925)

  • 1. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial.
    Hunter JG; Kahrilas PJ; Bell RC; Wilson EB; Trad KS; Dolan JP; Perry KA; Oelschlager BK; Soper NJ; Snyder BE; Burch MA; Melvin WS; Reavis KM; Turgeon DG; Hungness ES; Diggs BS
    Gastroenterology; 2015 Feb; 148(2):324-333.e5. PubMed ID: 25448925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm.
    Trad KS; Fox MA; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Barnes WE
    Surg Endosc; 2017 Jun; 31(6):2498-2508. PubMed ID: 27655380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial.
    Trad KS; Barnes WE; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Turgeon DG; Fox MA
    Surg Innov; 2015 Feb; 22(1):26-40. PubMed ID: 24756976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study.
    Trad KS; Simoni G; Barnes WE; Shughoury AB; Raza M; Heise JA; Turgeon DG; Fox MA; Mavrelis PG
    BMC Gastroenterol; 2014 Oct; 14():174. PubMed ID: 25284142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year outcome of laparoscopic and conventional nissen fundoplication: randomized clinical trial.
    Broeders JA; Rijnhart-de Jong HG; Draaisma WA; Bredenoord AJ; Smout AJ; Gooszen HG
    Ann Surg; 2009 Nov; 250(5):698-706. PubMed ID: 19801931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.
    Trad KS; Barnes WE; Prevou ER; Simoni G; Steffen JA; Shughoury AB; Raza M; Heise JA; Fox MA; Mavrelis PG
    Surg Innov; 2018 Apr; 25(2):149-157. PubMed ID: 29405886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.
    Richter JE; Kumar A; Lipka S; Miladinovic B; Velanovich V
    Gastroenterology; 2018 Apr; 154(5):1298-1308.e7. PubMed ID: 29305934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD.
    Frazzoni M; Conigliaro R; Manta R; Melotti G
    Aliment Pharmacol Ther; 2011 Jul; 34(1):67-75. PubMed ID: 21539587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-year results of a multicenter prospective study of transoral incisionless fundoplication.
    Muls V; Eckardt AJ; Marchese M; Bastens B; Buset M; Devière J; Louis H; Rajan A; Daniel MA; Costamagna G
    Surg Innov; 2013 Aug; 20(4):321-30. PubMed ID: 22968006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial.
    Bell R; Lipham J; Louie B; Williams V; Luketich J; Hill M; Richards W; Dunst C; Lister D; McDowell-Jacobs L; Reardon P; Woods K; Gould J; Buckley FP; Kothari S; Khaitan L; Smith CD; Park A; Smith C; Jacobsen G; Abbas G; Katz P
    Gastrointest Endosc; 2019 Jan; 89(1):14-22.e1. PubMed ID: 30031018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms.
    Trad KS; Turgeon DG; Deljkich E
    Surg Endosc; 2012 Mar; 26(3):650-60. PubMed ID: 21959689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Univariate and multivariate analyses of preoperative factors influencing symptomatic outcomes of transoral fundoplication.
    Bell RC; Fox MA; Barnes WE; Mavrelis PG; Sewell RW; Carter BJ; Ihde GM; Trad KS; Dargis D; Hoddinott KM; Freeman KD; Gunsberger T; Hausmann MG; Gill BD; Wilson E
    Surg Endosc; 2014 Oct; 28(10):2949-58. PubMed ID: 24879134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.
    Testoni PA; Testoni S; Mazzoleni G; Vailati C; Passaretti S
    Surg Endosc; 2015 Sep; 29(9):2770-80. PubMed ID: 25480624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication.
    Bell RC; Mavrelis PG; Barnes WE; Dargis D; Carter BJ; Hoddinott KM; Sewell RW; Trad KS; DaCosta Gill B; Ihde GM
    J Am Coll Surg; 2012 Dec; 215(6):794-809. PubMed ID: 22939637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year results of intermittent electrical stimulation of the lower esophageal sphincter treatment of gastroesophageal reflux disease.
    Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oxenberg D; Perez-Castilla A; Netto MG; Soffer E; Boscardin WJ; Crowell MD
    Surgery; 2015 Mar; 157(3):556-67. PubMed ID: 25726315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture.
    Wetscher GJ; Glaser K; Gadenstaetter M; Profanter C; Hinder RA
    Am J Surg; 1999 Mar; 177(3):189-92. PubMed ID: 10219852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ; Peters JH
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease.
    Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oksenberg D; Perez-Castilla A; Netto MG; Soffer E; Crowell MD
    Endoscopy; 2013 Aug; 45(8):595-604. PubMed ID: 23881803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.